Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us
  • Home
  • Frank van Leeuwen

Frank van Leeuwen

Principal Investigator
Dr. Frank van Leeuwen leads a research group in the Princess Máxima Center. His team focuses on genetic aberrations that lead to pediatric acute lymphoblastic leukemia.

Publications

89 publications in total

  • Loss of p53 impairs death receptor expression and confers resistance to CD19 CAR T-cell therapy in BCP-ALL

    • jan. 2025
    • Willem, Cox, et al
    • Blood Neoplasia

  • The role of the mineralocorticoid receptor in steroid-induced cytotoxicity in pediatric acute lymphoblastic leukemia

    • mei 2024
    • Annelienke M, Van Hulst, et al
    • Haematologica

  • Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy

    • dec. 2023
    • Willem P J, Cox, et al
    • Haematologica

  • Btg1 and Btg2 regulate neonatal cardiomyocyte cell cycle arrest

    • jun. 2023
    • Nivedhitha, Velayutham, et al
    • Journal of molecular and cellular cardiology

  • The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia

    • mei 2023
    • Anna, Østergaard, et al
    • HemaSphere
View all publications